And we were fortunate to secure Jon Develing, NHS Commissioning Board, North of England Regional Director of Operations and Delivery as our speaker.
His presentation: Opportunities for Excellence – A Changing NHS, gave delegates practical guidance on identifying and maximising partnership opportunities with Clinical Commissioning Groups and how to use localisation techniques to enhance marketing communications.
Commenting after his presentation, Jon said: “The main thing pharma companies looking to engage with the NHS need to do is make sure their products are aligned with its principles. That means speaking the right language, knowing who to have that conversation with and making an effort to understand the key priorities of the NHS. And then engaging early enough in the spirit of whole system change; ultimately this will help patients stay healthier for longer.”
Bray Leino has been working with the NHS for a number of years through the BroadCare system, which has been developed specifically for managing one of the NHS’s largest spend – Long Term Healthcare.
Developed in 2002 for one Primary Care Trust (PCT), the last four years has seen huge growth and expansion in this area as the population gets older and ever greater demands are put on NHS budgets.
The BroadCare system is now currently used in over 50 PCTs and now covers a variety of additional long term requirements.
Stephen Fletcher, MD of Bray Leino BroadCare commented: “The event underscored the challenges which we all face in engaging with the NHS post 1/4/13. BroadCare manages, maintains and monitors in excess of 1/3 £Billion of NHS spend in a variety of areas, but particularly in the field of long-term healthcare.
“Jon Develing generously mentioned the contribution to good governance that BroadCare (as the No1 system) brings in ensuring that taxpayers’ money is spent wisely, effectively and efficiently.
“Our challenge is engaging with clinical commissioning groups who will be taking responsibility from April 2013. They will face huge challenges themselves in the transitionary period and we believe we can assist in providing a solution.”
Commenting on the Partnerships in Practice event, ISBA’s Consultancy Manager, Traci Dunne said: “This event is a good example of healthcare professionals and their suppliers sharing a greater understanding towards mutually beneficial working relationships.
“There is a role for ISBA to highlight the benefits of good collaboration between pharma and the healthcare infrastructure to help other companies considering similar activities realise the potential benefits. ”